Top Healthcare stocks:
Healthcare shares were generally mixed in pre-market trade on
In healthcare stocks news, pharmaceutical giant Bristol-Myers
) released encouraging Phase 3 data from its study investigating
the all-oral, interferon- and ribavirin-free regimen of daclatasvir
and asunaprevir among genotype 1b hepatitis C virus or HCV-infected
And, Pfizer (
) said its subsidiary, King Pharmaceuticals Research &
Development and specialty pharmaceutical company Acura
) said Thursday that they will be terminating their license,
development and commercialization agreement covering ACUR's
proprietary drug abuse deterrent and tamper-resistant technologies,
AVERSION and OXECTA.
PFE shares were down 0.16% at $31.25, with a 52-week range of
$27.12 - $32.96.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.